Combination of Bevacizumab and Allogeneic NK Immunotherapy for Metastatic Solid Tumors
Clinical trial NCT02857920 · COMPLETED
Trial details
- NCT number
- NCT02857920
- Sponsor
- Fuda Cancer Hospital, Guangzhou
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-01
- Primary completion
- 2017-08-01
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.